Alexion (ALXN +1.8%) bounces back today after slipping despite a strong earnings report...

|About: Alexion Pharmaceuticals, Inc. (ALXN)|By:, SA News Editor

Alexion (ALXN +1.8%) bounces back today after slipping despite a strong earnings report yesterday. Jefferies ups its price target from $68 to $76 on the shares, saying that sales of its marquee drug Soliris were higher than expected. Canaccord agrees, noting that the stock is a solid earnings execution story.